Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
British Medical Journal|February 12, 1972
Neuropathy associated with hepatitis in patients maintained on haemodialysisA M Davison, I R Williams, C Mawdsley, et al.British Medical Journal|July 29, 1972
Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritisA R Clarkson, M K MacDonald, J D Cash, et al.The British Journal of Radiology|August 1, 1975
Periosteal new bone formation developing during haemodialysis for chronic renal failureW G Ritchie, R J Winney, A M Davison, et al.Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Plasma exchange in severe glomerulonephritis--who benefits?C P Swainson, R J Winney, S J Urbaniak, et al.Journal of Clinical Pathology|March 1, 1973
The role of the mesangial cell in proliferative glomerulonephritisA M Davison, D Thomson, M K MacDonald, et al.Clinical and Experimental Immunology|May 1, 1978
Treatment of Goodpasture's disease by plasma exchange and immunosuppressionC P Swainson, J S Robson, S J Urbaniak, et al.Archives of Emergency Medicine|September 1, 1984
The plasma kallikrein kinin system in severely ill and traumatised patientsA D Cumming, C E Robertson, S S Jeffrey, et al.Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1977
Oral or parenteral iron therapy in haemodialysis patients?R J Winney, C P Swainson, A C Parker, et al.British Medical Journal|August 1, 1971
Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritisA R Clarkson, M K MacDonald, J J Petrie, et al.Nephron|January 1, 1985
Proliferative glomerulonephritis and exposure to organic solventsG M Bell, A C Gordon, P Lee, et al.Pageof 3